Assessing the comparative effectiveness of a diagnostic technology: CT colonography.
Medical imaging is a prime example of an innovation that has brought important advances to medical care while triggering concerns about potential overuse and excessive costs. Many hopes are riding on comparative effectiveness research to help guide better decision making to improve quality and value. But the dynamic nature of medical imaging poses challenges for the traditional paradigms of evidentiary review and analysis at the heart of comparative effectiveness. This paper discusses these challenges and presents policy lessons for manufacturers, evidence reviewers, and decisionmakers, illustrated by an assessment of a prominent emerging imaging technique: computed tomography (CT) colonography.
Pearson
Steven D
SD
Institute for Clinical and Economic Review (ICER), Massachusetts General Hospital Institute for Technology Assessment (ITA) in Boston, USA. spearson@icer-review.org
Knudsen
Amy B
AB
Scherer
Roberta W
RW
Weissberg
Jed
J
Gazelle
G Scott
GS
D023881:Colonography, Computed Tomographic / Q000592:standards*; D015179:Colorectal Neoplasms / Q000175:diagnosis; D006302:Health Services Research; D006801:Humans; D016134:Organizational Policy; D011787:Quality of Health Care; D016896:Treatment Outcome